Clathrin therapeutic for neuropsychiatric diseases & disorders
OwnerFranco Vitaliano, Gordana Dragan Vitalianoinventors
Life of this patent
Estimating the term…
Abstract
The invention in suitable embodiments is directed to purified clathrin protein therapeutics. In one aspect, one or more purified clathrin protein therapeutic, formed in whole or in part from isolated, synthetic and or recombinant amino acid residues comprising in whole or in part one or more clathrin heavy chain protein and isoforms thereof, forms one or more type of therapeutic agent for treating neuropsychiatric diseases and disorders.
Claims33
A pharmaceutical composition, comprising at least one of a nanoparticle arrangement (NA) comprised of a plurality of clathrin protein nanoparticles and each NA is not a clathrin protein cage arrangement, each clathrin protein nanoparticle comprising one or more of a full length SEQ ID NO:1 or a humanized variant thereof, and the NA can pass through the blood brain barrier of a subject.
A method for a pharmaceutical composition, comprising:
- forming at least one of a nanoparticle arrangement (NA) comprised of a plurality of clathrin protein nanoparticles and each NA is not a clathrin protein cage arrangement, each clathrin protein nanoparticle comprising one or more of a full length SEQ ID NO:1 or a humanized variant thereof, and the NA can pass through the blood brain barrier of a subject, and using the composition for treating at least one of a neuropsychiatric disease, disorder, or a condition associated with neuropsychiatric, in the subject.
Dependencies are inferred from the claim text.